News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
672,018 Results
Type
Article (54826)
Company Profile (202)
Press Release (616981)
Multimedia
Podcasts (125)
Webinars (17)
Section
Business (184917)
Career Advice (2793)
Deals (33962)
Drug Delivery (132)
Drug Development (79743)
Employer Resources (170)
FDA (16825)
Job Trends (15411)
News (324527)
Policy (32991)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2868)
Accelerated approval (34)
Adcomms (35)
Allergies (146)
Alliances (46960)
ALS (175)
Alzheimer's disease (1726)
Antibody-drug conjugate (ADC) (334)
Approvals (17012)
Artificial intelligence (543)
Autoimmune disease (167)
Automation (38)
Bankruptcy (350)
Best Places to Work (11655)
BIOSECURE Act (19)
Biosimilars (203)
Biotechnology (138)
Bladder cancer (162)
Brain cancer (64)
Breast cancer (660)
Cancer (4905)
Cardiovascular disease (439)
Career advice (2377)
Career pathing (40)
CAR-T (299)
CDC (57)
Celiac Disease (2)
Cell therapy (785)
Cervical cancer (35)
Clinical research (68339)
Collaboration (1779)
Company closure (5)
Compensation (566)
Complete response letters (72)
COVID-19 (2959)
CRISPR (94)
C-suite (864)
Cystic fibrosis (149)
Data (6201)
Decentralized trials (2)
Denatured (29)
Depression (146)
Diabetes (522)
Diagnostics (6786)
Digital health (43)
Diversity (7)
Diversity, equity & inclusion (42)
Drug discovery (255)
Drug pricing (213)
Drug shortages (32)
Duchenne muscular dystrophy (239)
Earnings (73967)
Editorial (64)
Employer branding (22)
Employer resources (154)
Events (92690)
Executive appointments (1014)
FDA (19966)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1504)
Gene editing (206)
Generative AI (48)
Gene therapy (643)
GLP-1 (1100)
Government (5083)
Grass and pollen (8)
Guidances (384)
Healthcare (19026)
HIV (62)
Huntington's disease (48)
IgA nephropathy (85)
Immunology and inflammation (280)
Immuno-oncology (58)
Indications (101)
Infectious disease (3241)
Inflammatory bowel disease (194)
Inflation Reduction Act (14)
Influenza (116)
Intellectual property (245)
Interviews (519)
IPO (15174)
IRA (52)
Job creations (4066)
Job search strategy (1957)
JPM (68)
Kidney cancer (16)
Labor market (77)
Layoffs (634)
Leadership (39)
Legal (7582)
Liver cancer (99)
Longevity (15)
Lung cancer (668)
Lymphoma (376)
Machine learning (43)
Management (61)
Manufacturing (804)
MASH (168)
Medical device (13833)
Medtech (13882)
Mergers & acquisitions (19792)
Metabolic disorders (1368)
Multiple sclerosis (167)
NASH (21)
Neurodegenerative disease (350)
Neuropsychiatric disorders (96)
Neuroscience (3018)
Neurotech (1)
NextGen: Class of 2026 (6828)
Non-profit (4899)
Now hiring (55)
Obesity (666)
Opinion (310)
Ovarian cancer (164)
Pain (212)
Pancreatic cancer (223)
Parkinson's disease (295)
Partnered (33)
Patents (480)
Patient recruitment (486)
Peanut (59)
People (56932)
Pharmaceutical (36)
Pharmacy benefit managers (32)
Phase 1 (21242)
Phase 2 (29842)
Phase 3 (22832)
Pipeline (5187)
Policy (318)
Postmarket research (2588)
Preclinical (8328)
Press Release (63)
Prostate cancer (242)
Psychedelics (53)
Radiopharmaceuticals (269)
Rare diseases (897)
Real estate (5800)
Recruiting (74)
Regulatory (24895)
Reports (40)
Research institute (2590)
Resumes & cover letters (426)
Rett syndrome (28)
RNA editing (16)
RSV (84)
Schizophrenia (155)
Series A (253)
Series B (194)
Service/supplier (9)
Sickle cell disease (101)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (3635)
State (2)
Stomach cancer (19)
Supply chain (109)
Tariffs (97)
The Weekly (94)
Vaccines (1123)
Venture capital (96)
Weight loss (455)
Women's health (83)
Worklife (22)
Date
Today (88)
Last 7 days (519)
Last 30 days (1982)
Last 365 days (28827)
2026 (2857)
2025 (29165)
2024 (33571)
2023 (38278)
2022 (48997)
2021 (53442)
2020 (53155)
2019 (46987)
2018 (36088)
2017 (32832)
2016 (31882)
2015 (36111)
2014 (27762)
2013 (22934)
2012 (24678)
2011 (25438)
2010 (22771)
Location
Africa (955)
Alabama (86)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (40293)
Australia (6891)
California (10780)
Canada (2953)
China (1087)
Colorado (465)
Connecticut (444)
Delaware (284)
Europe (92344)
Florida (1523)
Georgia (333)
Hawaii (4)
Idaho (63)
Illinois (844)
India (65)
Indiana (504)
Iowa (21)
Japan (411)
Kansas (117)
Kentucky (41)
Louisiana (26)
Maine (82)
Maryland (1298)
Massachusetts (7033)
Michigan (312)
Minnesota (574)
Mississippi (6)
Missouri (133)
Montana (33)
Nebraska (28)
Nevada (120)
New Hampshire (84)
New Jersey (2755)
New Mexico (31)
New York (2751)
North Carolina (1368)
North Dakota (10)
Northern California (5156)
Ohio (303)
Oklahoma (21)
Oregon (41)
Pennsylvania (2012)
Puerto Rico (22)
Rhode Island (46)
South America (1309)
South Carolina (64)
South Dakota (1)
Southern California (4284)
Tennessee (168)
Texas (1603)
United States (36970)
Utah (347)
Vermont (1)
Virginia (255)
Washington D.C. (79)
Washington State (864)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
672,018 Results for "ferring holding sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene editing
FDA Lifts One of Two Clinical Holds on Intellia’s ATTR Gene Editing Program
After a patient safety signal and then death, the FDA in October 2025 placed holds on two of the company’s CRISPR programs for hereditary transthyretin amyloidosis.
January 27, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
January 12, 2026
·
10 min read
Layoffs
Ferring’s Shift to New Business Model Claims 500 Jobs Worldwide
The layoffs are part of the company’s shift to a new structure enabling cost efficiency for its new model.
October 9, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
January 12, 2026
·
13 min read
Press Releases
SUO and Ferring Pharmaceuticals Announce the SUO Non-Muscle Invasive Bladder Cancer (NMIBC) Fellows Research Grant
December 3, 2025
·
8 min read
Press Releases
Ferring Pharmaceuticals Presents Two New Analyses of Pivotal Trial Data for Follitropin Delta (FE 999049) at ASRM 2025
October 28, 2025
·
6 min read
Press Releases
Ferring Highlights New Real-World Research with ADSTILADRIN® (nadofaragene firadenovec-vncg) in Clinical Practice
October 29, 2025
·
11 min read
Press Releases
Battelle Named Key Subcontractor to SA-TECH for Mission Support Services Contract at U.S. Army Dugway Proving Ground
January 30, 2026
·
3 min read
Press Releases
POXEL SA: Update on the Proposed Recovery Plan and Organisation of a Webinar
November 24, 2025
·
19 min read
Press Releases
Ferring Presents New Data Analyses for REBYOTA® (fecal microbiota, live – jslm) at ACG 2025
October 28, 2025
·
8 min read
1 of 67,202
Next
